What is the difference between TB-500 and Thymosin Beta-4?

Thymosin Beta-4 (Tβ4) is the full naturally-occurring 43-amino-acid protein your body produces. TB-500 is a synthetic 7-amino-acid fragment (LKKTETQ) that contains the actin-binding domain — the part responsible for most of Tβ4's repair activity. TB-500 is also acetylated at the N-terminus for extra stability. The two terms are sometimes used interchangeably in research literature, but they are technically distinct compounds. Research suggests the smaller TB-500 fragment retains most of the repair activity in a more practical format.

How does TB-500 compare to BPC-157?

They are siblings — often studied together because they appear to work on complementary aspects of tissue repair. BPC-157 amplifies growth factor signalling and supports angiogenesis through pathways like VEGFR2 and nitric oxide. TB-500 helps cells migrate to where repair is needed, primarily through actin regulation. Picture BPC-157 as amplifying the "build here" signal at a wound site, and TB-500 as helping the cellular workers actually reach the site. Research on combinations of the two is an active area in the recovery peptide literature.

Is Thymosin Beta-4 really naturally occurring in the body?

Yes — and it is unusually abundant. Research suggests Tβ4 is one of the most common intracellular proteins in mammals, present in nearly every cell type except red blood cells. Concentrations are highest in platelets, white blood cells, and wound fluid — which is why some sources describe it as the body's natural wound-deployed protein. Your body produces it and physically delivers it to injury sites. The synthetic TB-500 used in research is a copy of its active fragment.

Have any human clinical trials been completed?

Thymosin Beta-4 has been in clinical trials, primarily through a company called RegeneRx Biopharmaceuticals — including trials for corneal wounds, skin wounds, and cardiac tissue research. TB-500 itself, as the synthetic active-fragment version, is classified as a research compound and is not approved for therapeutic use anywhere. Research suggests substantial preclinical activity, but the clinical evidence base is much smaller than for FDA-approved peptides.

Why is cell migration so important to tissue repair?

Almost every kind of healing depends on cells reaching the right place at the right time. New blood vessels form because endothelial cells migrate. Wounds close because skin cells migrate over the gap. Muscle regenerates because satellite cells migrate to damaged fibres. Nerve healing depends on supporting cells migrating along the path the nerve needs to regrow. Block cell migration, and you block almost all repair. This is why a peptide that supports cell migration tends to show effects across many different tissue types — it is acting on a process every kind of healing shares.

Research Library›Recovery & Tissue Repair›TB-500

Tissue Repair Peptide

TB-500: The Complete Guide

A synthetic fragment of Thymosin Beta-4 — a protein your body already produces and deploys at every wound site. One of the most broadly studied tissue repair peptides in the published research literature.

8 min read·4 studies cited·Updated April 2026

Evidence level

Preclinical only — animal and cell studies

What this level means

Quick Reference

Also Known As	Thymosin Beta-4 Fragment
Active Sequence	Ac-LKKTETQ
Target	Actin / cell migration
Source	Naturally found in nearly all human cells
Storage	Refrigerate (2–8°C)

What is TB-500?

Like BPC-157, TB-500 is one of those peptides where the natural version already exists inside you. The parent protein — Thymosin Beta-4 — is found in nearly every cell in the human body except red blood cells. It is one of the most abundant intracellular proteins we have. Levels are highest in platelets, white blood cells, and wound fluid — which tells you something important about what it does. Your body produces this protein and physically deploys it at injury sites. It is part of the natural repair signalling system.

TB-500 is the synthetic version of the active fragment of that protein — specifically a 7-amino-acid sequence (LKKTETQ) that contains the actin-binding domain responsible for most of Thymosin Beta-4's repair activity. The full natural protein is 43 amino acids long; TB-500 retains the part that does the heavy lifting in a smaller, more stable, research-practical format. The acetyl group at the front (the "Ac-" in Ac-LKKTETQ) provides extra stability against breakdown.

What sets TB-500 apart in the recovery research family is breadth. Most tissue-repair peptides have a primary research focus — one or two tissue types where the data is concentrated. TB-500 has substantial published research across skin wounds, muscle, tendons and ligaments, cardiac tissue, neurological tissue, corneal tissue, and hair follicles. Research suggests this breadth comes from the fact that TB-500 acts on a process every type of repair shares: cell migration. If BPC-157 amplifies the "build here" signals at a wound site, TB-500 helps the cells doing the actual building reach where they need to go.

Research Applications

Research on TB-500 is unusually broad — which is part of what makes it interesting alongside BPC-157 in tissue repair research. The published literature has examined effects across remarkably different tissue types, all linked by the same underlying mechanism (cell migration).

🩹

Skin Wound Research

TB-500's most foundational application — the field where Thymosin Beta-4 was first characterised as a wound-healing factor. Research suggests treated wounds close faster, with increased collagen organisation and reduced scarring in animal models. The original Malinda 1999 study (Journal of Investigative Dermatology) is the foundational paper.

💪

Muscle and Tendon Research

Tendons heal slowly because they have very limited blood supply. Research suggests TB-500 supports both blood vessel formation (so nutrients reach the damage site) and muscle fibre regeneration (so the rebuilding work can happen). Two different repair problems addressed by one peptide.

🫀

Cardiac Tissue Research

The heart is famously bad at repairing itself — cardiac muscle does not regenerate the way skin does. Research models examining heart attack recovery (using induced cardiac injury in animals) have included TB-500 as a study compound, with research suggesting reduced damage and preserved cardiac function in those models.

🧬

Blood Vessel Formation

Repair depends on getting blood flow to damaged tissue — oxygen, nutrients, immune cells, all delivered through new blood vessels (a process called angiogenesis). Research suggests TB-500 supports this process. This single mechanism may explain why it appears active across so many different tissue types.

🧠

Brain and Spinal Cord Research

Nerve tissue famously does not heal the way other tissues do — one reason being that scar tissue forms quickly and physically blocks regrowing nerve fibres. Research suggests TB-500 reduces neural scarring in animal models, an active research area in spinal cord and traumatic brain injury studies.

🔗

Cell Migration as the Core Mechanism

Every research finding above shares one underlying process: cells reaching the damage site. Research suggests TB-500's primary action is regulating actin (the cellular skeleton protein that lets cells move and reshape themselves). Control the cellular skeleton, and you control whether cells can migrate to where repair is needed.

How TB-500 Works

The big-picture answer first: tissue repair fundamentally depends on cells getting from where they are to where they are needed. Research suggests TB-500's main job is making that movement possible by regulating actin — the protein that lets cells reshape themselves and crawl through tissue. This sounds like a small thing, but it underlies almost every kind of healing your body does.

Actin regulation, in plain language: imagine the inside of every cell as a constantly rebuilding scaffold — the cell can extend a "leg," anchor it ahead, then pull the rest of itself forward. The scaffold is made of actin. Research suggests TB-500 binds to free-floating actin molecules and holds them in reserve, so the cell can release and assemble them precisely when and where they are needed. Without that careful control, cells cannot crawl, cannot extend projections, cannot move toward an injury site. With it, repair becomes possible.

Cell migration in numbers: early research (Malinda et al. 1999) examined how skin cells (keratinocytes) responded to Thymosin Beta-4 in cell culture. Research suggested cells migrated 2–3 times faster than untreated controls, even at extraordinarily low concentrations — down to 10 picograms (a picogram is one trillionth of a gram). That kind of potency at near-imperceptible doses is one of the things that put Thymosin Beta-4 on the regenerative-research map in the first place.

Anti-inflammatory effects: healing is not just about building — it is also about resolving inflammation cleanly. Inflammation that lingers too long causes secondary damage and scarring. Research suggests TB-500 helps downregulate inflammatory chemokines and cytokines in wound environments, supporting a faster transition out of the inflammatory phase and into actual rebuilding.

Reduced scarring: scar tissue forms when cells called myofibroblasts deposit excessive collagen at a wound site — leaving rigid, non-functional tissue instead of the normal architecture. Research suggests TB-500 reduces myofibroblast accumulation, which in animal models is associated with less fibrosis and more normal-looking tissue once the repair is complete. That matters: scarring is not just cosmetic, it is a failure mode that often limits how well a tissue actually works after injury.

Storage Guidelines

Store at 2–8°C in a cool, dry place. Protect from light and moisture. Refrigerate once in solution form.

Frequently Asked Questions

Technical Specifications

Full Name	TB-500 (Thymosin Beta-4 Fragment)
Active Sequence	Ac-LKKTETQ
Parent Protein	Thymosin Beta-4 (Tβ4, 43 amino acids)
Molecular Weight (Full Tβ4)	~4963 g/mol
CAS Number	77591-33-4
Appearance	White to off-white lyophilised powder
Solubility	Soluble in water
Storage (Powder)	2–8°C refrigerated, -20°C long-term
Storage (Solution)	2–8°C, do not freeze
Origin	Synthetic fragment of natural human Tβ4

Compiled by the Southern Pacific Labs research team. Last updated April 2026.

Browse the research range →

Published References

Malinda KM, Sidhu GS, Mani H, et al. “Thymosin beta4 accelerates wound healing.” The Journal of investigative dermatology, 1999. PubMed
The foundational wound-healing paper. Showed Thymosin Beta-4 dramatically accelerated skin cell migration in cell-culture and animal models, even at vanishingly small concentrations. The study that put TB-500 on the regenerative research map.
Goldstein AL, Hannappel E, Sosne G, et al. “Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.” Expert opinion on biological therapy, 2012. PubMed
A comprehensive review by one of the original Thymosin Beta-4 researchers, summarising the breadth of repair activity across skin, heart, brain, and other tissues. Useful as a starting point for understanding why this peptide works on so many systems.
Sosne G, Qiu P, Kurpakus-Wheater M. “Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.” Clinical ophthalmology (Auckland, N.Z.), 2007. PubMed
Examined Thymosin Beta-4 in corneal wound healing — one of the more advanced clinical research programmes for this peptide family. Important for understanding the trajectory from preclinical research toward eventual clinical applications.
Maar K, Hetenyi R, Maar S, et al. “Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies.” Cells, 2021. PubMed
A more recent review framing Thymosin Beta-4 within the broader "developmental peptide" research category — the idea that some peptides active during embryonic tissue formation can be used to support repair in adult tissue.

Browse all TB-500 research on PubMed →